title: Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL.
authors.forename: A L
authors.initials: AL
authors.lastname: Moreira
authors.forename: G
authors.initials: G
authors.lastname: Kaplan
authors.forename: L G
authors.initials: LG
authors.lastname: Villahermosa
authors.forename: T J
authors.initials: TJ
authors.lastname: Fajardo
authors.forename: R M
authors.initials: RM
authors.lastname: Abalos
authors.forename: R V
authors.initials: RV
authors.lastname: Cellona
authors.forename: M V
authors.initials: MV
authors.lastname: Balagon
authors.forename: E V
authors.initials: EV
authors.lastname: Tan
authors.forename: G P
authors.initials: GP
authors.lastname: Walsh
mesh_terms: D000293:Adolescent; D000328:Adult; D016207:Cytokines / Q000097:blood; D004893:Erythema Nodosum / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015440:Leprosy, Lepromatous / Q000097:blood / Q000188:drug therapy*; D008297:Male; D010431:Pentoxifylline / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D018121:Receptors, Cytokine / Q000097:blood; D013792:Thalidomide / Q000627:therapeutic use*
chemical_list: D016207:Cytokines; D018121:Receptors, Cytokine; D013792:Thalidomide; D010431:Pentoxifylline; D011241:Prednisone